跳至主要内容
临床试验/NCT04488562
NCT04488562已完成不适用

Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands

Erasmus Medical Center3 个研究点 分布在 1 个国家目标入组 133 人开始时间: 2020年3月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
133
试验地点
3
主要终点
VAS

研究概览

简要总结

To date, little is known about the short and long-term complications of COVID-19. In order to obtain more insights in disease course and recovery of COVID-19 and to improve care after hospital admission, patients with COVID-19 will be monitored at home using an online home monitoring program for a period of 1 year.

详细描述

Patients with COVID-19 have a variable disease course and recovery. After the SARS coronavirus outbreak in 2003, many patients developed pulmonary fibrosis. Emerging data from the COVID-19 outbreak suggests that a substantial number of patient will likely develop pulmonary fibrosis. However, much is still unknown (e.g. the percentage of patients who develop pulmonary fibrosis, progression of fibrosis). Since we have little knowledge on the disease course and long-term complications of COVID-19, it is very important to properly monitor patients after hospital admission. An online home monitoring program could be an efficient way to monitor disease course of COVID-19 and provide insights in the long-term effects of COVID-19.

In this prospective, observational multi center study we aim to include 150 patients that were admitted in the hospital with abnormalities on chest X-ray/HRCT due to COVID-19. Based on their clinical status, patients will be either included at time of discharge from the hospital or at time of their regular outpatient clinic visit, 6 weeks after discharge from the hospital. Patients will be monitored for a period of 1 year after admission, after signing informed consent. Home monitoring, consisting of real-time lung function measures and PROMs, has been developed and validated for patients with pulmonary fibrosis; home monitoring was feasible, FVC measurements were reliable and patient satisfaction was high.

Patients are asked to fill in a diary once weekly (consisting of Visual Analogue Scales on cough, dyspnea, fatigue, general well-being, and temperature and oxygen measurements) and measure their lung function (FVC) at home every week with a home spirometer (Spirobank Smart, MIR, Italy) (duration + -2 min). The spirometer is connected via Bluetooth with the secured app and results can be sent directly to the study team. Patients are instructed to contact the hospital using a secured eConsult if they have worsening complaints and/or have a decrease in saturation or lung function.

Patients are asked to fill complete short validated questionnaires (ABC tool, EQ5D-5L, Fatigue Assessment Scale and Global rating of change, duration + - 10 minutes) in the app, at time of discharge, 6 weeks, 3 months, 6 months, 9 months and 12 months after discharge.

Demographic data, clinical characteristics, lung function results, radiology data and data about medication will be collected from the electronic patient file during regular outpatient clinic visits.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients admitted to the hospital with proven COVID-19 infection
  • Abnormalities on Chest X-ray/HRCT due to COVID-19 infection

排除标准

  • Not able to speak, read or write in the native language of the country where the patient is included
  • Not able to comply to the study protocol, according to the judgement of the investigator and/or patient
  • No access to internet

结局指标

主要结局

VAS

时间窗: 12 months

Visual Analogue Scale: scores on fatigue, dyspnea, cough and general wellbeing on a scale ranging from 0-10. Higher score indicates more complaint.

Oxygen measurements

时间窗: 12 months

Oxygen saturation measured with an pulse oximeter

Forced Vital Capacity (FVC) home spirometry in %

时间窗: 12 months

FVC change measured with home spirometry at 12 months (in %)

Forced Vital Capacity (FVC) home spirometry in L

时间窗: 12 months

FVC change measured with home spirometry at 12 months (in L)

FAS

时间窗: 12 months weeks

Fatigue Assessment Scale: 10-item questionnaire about fatigue FAS. The fatigue assessment scale (FAS) is a 10-item self-administered questionnaire about fatigue in patients with sarcoidosis. The score ranges from 5-50 points, with a score of ≥ 22 points as cut-off for fatigue. The minimal important difference (MID) is 4 points or a 10% lower score. It will take about 1-2 minutes to complete.

ABC tool

时间窗: 12 months

Questionnaire consisting of five domains: symptoms, functional state, mental state, emotions and fatigue, smoking status, exacerbations, dyspnoea, body mass index, lung function and self-reported physical activity. Outcomes are visualized using coloured balloons. green balloons indicate a satisfactory score, red balloons a low score and orange balloons an intermediate score. Grey balloons represent the balloons of previous visits.

Temperature

时间窗: 3 months

Body temperature measured with an thermometer

Forced Vital Capacity (FVC) hospital spirometry in %

时间窗: 12 months

FVC change measured with hospital spirometry and saturation at 12 months (in %)

EQ5D

时间窗: 12 months

The EuroQol five dimensions 5-level questionnaire: 6-item questionnaire on five dimensions: The EuroQol five dimensions 5-level questionnaire is a standardized instrument to measures health outcomes in two components: health description and valuation. It comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Higher score indicates a poorer health status

Forced Vital Capacity (FVC) hospital spirometry in L

时间窗: 12 months

FVC change measured with hospital spirometry and saturation at 12 months (in L)

Adherence to weekly home spirometry

时间窗: 1 year after inclusion

The percentage of patients completed weekly home spirometry

GRoC

时间窗: 12 months

Global Rating of Change Scales: Global rating of change (GRC) scales provide a method of obtaining information about improving or deteriorated of health condition of patients over time. Patients are asked to make global ratings on changes in regards to their well-being on a 15-point self-report scale (from -7 to 7 ). It will take about 1 minute to complete. Higher score indicates a better health condition.

次要结局

  • Satisfaction of patients and caregivers with the use of a home monitoring system(12 months)
  • Correlation between FVC, HRCT patterns, symptoms and quality of life(12 months)
  • Predictors for the course of recovery of COVID-19 infection after hospital admission(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marlies Wijsenbeek

Principal Investigator

Erasmus Medical Center

研究点 (3)

Loading locations...

相似试验